Stensen duct dilation: Case series of minimally invasive treatment.

Affiliation

Oral and Maxillofacial Surgery Department, University Hospital Center Conception, Marseille, France; Aix Marseille University, SPMC EA 3279, Marseille, France. Electronic address: [Email]

Abstract

Stensen's duct dilation is a rare condition characterized by a global or partial idiopathic dilation of the Stensen duct. Affected individuals usually show either aesthetically compromised features, such as a tubular-shaped swelling in the cheek, or with mildly painful inflammatory episodes. Three women between ages 61 and 67 years were diagnosed with Stensen duct dilation after sialo-magnetic resonance imaging (MRI). They were treated with botulinum toxin A (BTX-A). Our preliminary results suggest that BTX-A was efficient as a suspensive treatment. BTX-A should remain a first-line treatment of the early silent symptoms of Stensen duct dilation, such as swelling and aesthetic issues. The use of BTX-A avoids more serious procedures and further complications.

OUR Recent Articles